Coronavirus inhibitor in human sera: age distribution and prevalence
Debiaggi, M.; Perduca, M.; Cereda, P.M.; Romero, E.
Microbiologica 9(1): 109-112
1986
ISSN/ISBN: 0391-5352 PMID: 3005804 Document Number: 282042
We studied the distribution, in human sera, of non antibody serum inhibitor active towards human OC43 and bovine NCDCV coronaviruses. Antibodies to coronaviruses, present with high prevalence in human sera, were filtered by Protein A Sepharose CL 4B column. In the present work we tested sera of newborns, infants, young children and adults. Inhibitory activity was revealed in all sera except these from newborns. This non antibody inhibitor was tested by a plaque-reduction assay.
Document emailed within 1 workday
Related Documents
May, J.T.; Stent, G.; Bishop, F.; Schnagl, D. 1990: Prevalence of antibody to human T-lymphotropic virus type-1 (HLTV-1) in Australian aborigines, and detection in Indonesian sera Acta Virologica 34(1): 80-84Shibata, T.; Ogawa, M.; Takata, N.; Matsuda, K.; Niinobu, T.; Uda, K.; Wakasugi, C.; Mori, T. 1987: Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa Research Communications in Chemical Pathology and Pharmacology 55(2): 243-248
Kawanishi, T.; Itamura, S.; Saida, T.; Kameyama, M.; Hatanaka, M. 1987: Prevalence and immunological properties of antibodies reactive with human T lymphotropic virus type i (HTLV-I) in sera from multiple sclerosis patients Rinsho Shinkeigaku 27(8): 963-968
Darwish, M.A.; Ibrahim, A.H. 1971: Survey for antibodies to arboviruses in Egyptian sera. I. West Nile virus antihemagglutinins in human and animal sera Journal of the Egyptian Public Health Association 46(2): 61-70
Wall, R.T.; Harlan, J.M.; Harker, L.A.; Striker, G.E. 1980: In vitro effects of hyperlipoproteinemic sera on human endothelium: inhibition of endothelial cell migration by familial hypercholesterolemic sera Thrombosis Research 17(6): 753-765
Yip, Y.-C.; Ngai, K.L.K.; Vong, H.-T.; Tzang, L.C.H.; Ji, S.; Yang, M.; Chan, P.K.S. 2010: Prevalence and genotype distribution of cervical human papillomavirus infection in Macao Journal of Medical Virology 82(10): 1724-1729
Olesen, T.B.; Iftner, T.; Mwaiselage, J.; Kahesa, C.; Rasch, V.; Ngoma, T.; Munk, C.; Kjaer, S.K.üg. 2013: Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status Sexually Transmitted Diseases 40(7): 592-598
Aiuti, F.; Wigzell, H. 1973: Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes Clinical and Experimental Immunology 13(2): 171-181
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891
Basova, E.N.; Stefani, D.V.; Kazantseva, L.Z. 1979: Human IgG subclass study. II. the levels of the individual IgG subclasses in paired sera from mothers and newborn infants as well as in the blood sera of inhabitants of an isolated northern village Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 7: 35-39
Rai, G.; Ryan, C. 2011: Epidemiological surveillance of human papillomavirus prevalence and type distribution in Papua New Guinea: the selection of an appropriate laboratory tool Papua and new Guinea Medical Journal 54(3-4): 132-138
Li, H.-M.; Liang, G.-J.; Yin, Y.-P.; Wang, Q.-Q.; Zheng, Z.-J.; Zhou, J.-J.; Jiang, N.; Tan, G.-J.; Wang, B.; Chen, X.-S. 2012: Prevalence and genotype distribution of human papillomavirus infection among female sex workers in Guangxi, China: implications for interventions Journal of Medical Virology 84(5): 798-803
Ikegami, Y.; Yano, S.; Nakao, K. 1996: Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cells Arzneimittel-Forschung 46(2): 201-204
Málková, D.; Holubová, J.; Kolman, J.M.; Lobkovic, F.; Pohlreichová, L.; Zikmundová, L. 1980: Detection of coronavirus in human cerebrospinal fluid? Casopis Lekaru Ceskych 119(8): 233-236
Terao, Y.; Takagi, H.; Phan, T.G.; Okitsu, S.; Ushijima, H. 2007: Identification of Antibody Against Porcine Coronavirus in Human Milk Clinical Laboratory 53(3-4): 129-130
Peng, R-Rui.; Li, H-Min.; Chang, H.; Li, J-Hong.; Wang, A.L.; Chen, X-Sheng. 2012: Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis Sexual Health 9(2): 113-119
Wang, Z.G.; Xu, S.P.; Zhang, Y.J. 2006: The possible origin of recent human SARS coronavirus isolate from China Acta Virologica 50(3): 211-213
Hyatt, R.; Tan-ariya, P.; Paca-uccaralertkun, S.; Mungthin, M.; Poungpong, S. 2014: Prevalence and gB genotype distribution of human cytomegalovirus among HIV sero-negative and HIV sero-positive orphans in Thailand Journal of the Medical Association of Thailand 97(Suppl 2): S136-S144
Golshmid, V.K.; Vlasovskaia, O.N.; Egorov, E.V.; Makarova, S.B.; Podgornova, G.P. 1974: Properties of the Soviet dextran gel ED-20 and its use for studying antibody distribution in sera Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 51(6): 136-137
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816